Cite
HARVARD Citation
Hoivik, M. et al. (n.d.). P705 Switching from originator to biosimilar infliximab—real-world data from 18 months prospective follow-up of a single-centre IBD population. Journal of Crohn's and colitis. pp. S467-S468. [Online].